NA
Nilesh Avinash Limaye
About Nilesh Avinash Limaye
Data last updated:
Nilesh Avinash Limaye has 15 years in corporate governance. Holds Director role. Currently with 2 companies, including Roche Products (India) Private Limited and Roche India Healthcare Institute. Formerly with 5 companies, such as Fmc India Private Limited and Cheminova India Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Director | 01 Apr 2025 | 1994 | Active | |
| Director | 26 Feb 2024 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Company Secretary | 24 Oct 2018 | 2000 | Active | |
| Director | 22 Jun 2017 | 1986 | Active | |
| Company Secretary | 25 Nov 2015 | 1948 | Active | |
| Company Secretary | 28 Apr 2011 | 2011 | Active | |
| Director | 21 May 2018 | 2018 | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nilesh Avinash Limaye
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nilesh Avinash Limaye
Nilesh Avinash Limaye has 15 years in corporate governance. Holds Director role. Currently with 2 companies, including Roche Products (India) Private Limited and Roche India Healthcare Institute. Formerly with 5 companies, such as Fmc India Private Limited and Cheminova India Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Nilesh Avinash Limaye is associated with 2 companies as Director.
Nilesh Avinash Limaye has expertise in General Business, Healthcare.
Nilesh Avinash Limaye has 15 years in corporate governance.